MULTIDIMENSIONAL BURDEN OF CHRONIC KIDNEY DISEASE IN EIGHT COUNTRIES: INSIGHTS FROM THE IMPACT CKD STUDY

https://storage.unitedwebnetwork.com/files/1099/6dccc23467ee178bdf0550057cef9881.pdf
MULTIDIMENSIONAL BURDEN OF CHRONIC KIDNEY DISEASE IN EIGHT COUNTRIES: INSIGHTS FROM THE IMPACT CKD STUDY
Ana Flavia
Moura
David Wheeler d.wheeler@ucl.ac.uk University College London Department of Renal Medicine London
Francisco Brotons-Munto brotonsfra@gmail.com Centro de Salud Trinitat Departamento de Salud La Fe Valencia
Stephen Brown stephen.brown@eversana.com EVERSANA Value & Evidence Services Burlington
Daniel Grima daniel.grima@eversana.com EVERSANA Value & Evidence Services Burlington
Stacey Priest stacey.priest@eversana.com EVERSANA Value & Evidence Services Burlington
Naveen Rao naveen.rao@astrazeneca.com AstraZeneca BioPharmaceuticals Medical Cambridge
Janwillem W.H. Kocks janwillem@gpri.nl Observational and Pragmatic Research Institute Inhalation Medicine Singapore
Zhao Ming-Hui mhzhao@bjmu.edu.cn Peking University First Hospital Institute of Nephrology Beijing
Kyra Obolensky kyra.obolensky@astrazeneca.com AstraZeneca BioPharmaceuticals Medical Cambridge
Jieling Chen jieling.chen@astrazeneca.com AstraZeneca BioPharmaceuticals Medical Gaithersburg
Stephen Chadban steve.chadban@health.nsw.gov.au Royal Prince Alfred Hospital Department of Renal Medicine Camperdown